.JPG) | |
| Established | 1979 |
|---|---|
| President | Deepak Srivastava |
| Faculty | 30 |
| Staff | 450 |
| Budget | $80 million |
| Address | 1650 Owens St., San Francisco, CA |
| Location | , , |
| Coordinates | 37°46′03″N 122°23′39″W / 37.7676°N 122.3941°W |
| Website | gladstoneinstitutes |
Gladstone Institutes is an American independent, non-profit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease.[1] Its researchers study these diseases using techniques of basic and translational science.[2] Another focus at Gladstone is building on the development of induced pluripotent stem cell technology by one of its investigators, 2012 Nobel Laureate Shinya Yamanaka, to improve drug discovery, personalized medicine and tissue regeneration.[3]
Founded in 1979, Gladstone is academically affiliated with the University of California, San Francisco (UCSF), and located adjacent to UCSF's Mission Bay campus. The organization comprises five major institutes, as well as multiple centers focused on various areas of research.
The current president of the institute is Deepak Srivastava.
- ^ Leuty, Ron (July 27, 2012). "Gladstone boosts funding, science and fame". www.bizjournals.com. Retrieved February 19, 2020.
- ^ Leuty, Ron (July 24, 2012). "Gladstone, Jesse Dylan collaborate as research institute rebrands". San Francisco Business Times. Retrieved June 26, 2019 – via bizjournals.com.
- ^ Allday, Erin (October 19, 2011). "Gladstone to announce new stem cell center". SFGate. Retrieved February 19, 2020.